Skip to main content
NCBI home page
Gut logoLink to Gut
. 1992 Sep;33(9):1204–1208. doi: 10.1136/gut.33.9.1204

Metronidazole reduces intestinal inflammation and blood loss in non-steroidal anti-inflammatory drug induced enteropathy.

I Bjarnason 1, J Hayllar 1, P Smethurst 1, A Price 1, M J Gumpel 1
PMCID: PMC1379487  PMID: 1427372

Abstract

This study assessed the effect of metronidazole on the gastroduodenal mucosa, intestinal permeability, blood loss, and inflammation in patients on non-steroidal anti-inflammatory drugs (NSAIDs). Thirteen patients were studied before and after 2-12 weeks' treatment with metronidazole 800 mg/day, while maintaining an unchanged NSAID intake. Intestinal inflammation, as assessed by the faecal excretion of indium-111 labelled neutrophils, and blood loss, assessed with chromium-51 labelled red cells, were significantly reduced after treatment (mean (SD) 111In excretion 4.7 (4.7)% v 1.5 (1.3)% (N < 1.0%), p < 0.001, 51Cr red cells loss 2.6 (1.6) ml/day v 0.9 (0.5) ml/day (N < 1.0 ml/day), p < 0.01). Intestinal permeability assessed as the 5 hour urinary excretion ratio of 51CrEDTA/L-rhamnose did not change significantly (0.133 (0.046) v 0.154 (0.064), p > 0.1) and there were no significant changes in the endoscopic or microscopic appearances of the gastroduodenal mucosa. These results suggest that the neutrophil is the main damaging effector cell in NSAID induced enteropathy. The main neutrophil chemo-attractant in this enteropathy may be a metronidazole sensitive microbe.

Full text

PDF
1204

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong C. P., Blower A. L. Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration. Gut. 1987 May;28(5):527–532. doi: 10.1136/gut.28.5.527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bartle W. R., Gupta A. K., Lazor J. Nonsteroidal anti-inflammatory drugs and gastrointestinal bleeding. A case-control study. Arch Intern Med. 1986 Dec;146(12):2365–2367. [PubMed] [Google Scholar]
  3. Bjarnason I., Macpherson A. The changing gastrointestinal side effect profile of non-steroidal anti-inflammatory drugs. A new approach for the prevention of a new problem. Scand J Gastroenterol Suppl. 1989;163:56–64. doi: 10.3109/00365528909091176. [DOI] [PubMed] [Google Scholar]
  4. Bjarnason I., Price A. B., Zanelli G., Smethurst P., Burke M., Gumpel J. M., Levi A. J. Clinicopathological features of nonsteroidal antiinflammatory drug-induced small intestinal strictures. Gastroenterology. 1988 Apr;94(4):1070–1074. doi: 10.1016/0016-5085(88)90568-9. [DOI] [PubMed] [Google Scholar]
  5. Bjarnason I., Smethurst P., Fenn C. G., Lee C. E., Menzies I. S., Levi A. J. Misoprostol reduces indomethacin-induced changes in human small intestinal permeability. Dig Dis Sci. 1989 Mar;34(3):407–411. doi: 10.1007/BF01536263. [DOI] [PubMed] [Google Scholar]
  6. Bjarnason I., Williams P., Smethurst P., Peters T. J., Levi A. J. Effect of non-steroidal anti-inflammatory drugs and prostaglandins on the permeability of the human small intestine. Gut. 1986 Nov;27(11):1292–1297. doi: 10.1136/gut.27.11.1292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bjarnason I., Williams P., So A., Zanelli G. D., Levi A. J., Gumpel J. M., Peters T. J., Ansell B. Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs. Lancet. 1984 Nov 24;2(8413):1171–1174. doi: 10.1016/s0140-6736(84)92739-9. [DOI] [PubMed] [Google Scholar]
  8. Bjarnason I., Zanelli G., Smith T., Prouse P., Williams P., Smethurst P., Delacey G., Gumpel M. J., Levi A. J. Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humans. Gastroenterology. 1987 Sep;93(3):480–489. doi: 10.1016/0016-5085(87)90909-7. [DOI] [PubMed] [Google Scholar]
  9. Bjarnason I., Zanelli G., Smith T., Smethurst P., Price A. B., Gumpel M. J., Levi A. J. The pathogenesis and consequence of non steroidal anti-inflammatory drug induced small intestinal inflammation in man. Scand J Rheumatol Suppl. 1987;64:55–62. doi: 10.3109/03009748709096722. [DOI] [PubMed] [Google Scholar]
  10. Collier D. S., Pain J. A. Non-steroidal anti-inflammatory drugs and peptic ulcer perforation. Gut. 1985 Apr;26(4):359–363. doi: 10.1136/gut.26.4.359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Collins A. J., Du Toit J. A. Upper gastrointestinal findings and faecal occult blood in patients with rheumatic diseases taking nonsteroidal anti-inflammatory drugs. Br J Rheumatol. 1987 Aug;26(4):295–298. doi: 10.1093/rheumatology/26.4.295. [DOI] [PubMed] [Google Scholar]
  12. Hansen T. M., Hansen N. E., Birgens H. S., Hølund B., Lorenzen I. Serum ferritin and the assessment of iron deficiency in rheumatoid arthritis. Scand J Rheumatol. 1983;12(4):353–359. doi: 10.3109/03009748309099740. [DOI] [PubMed] [Google Scholar]
  13. Jenkins R. T., Rooney P. J., Jones D. B., Bienenstock J., Goodacre R. L. Increased intestinal permeability in patients with rheumatoid arthritis: a side-effect of oral nonsteroidal anti-inflammatory drug therapy? Br J Rheumatol. 1987 Apr;26(2):103–107. doi: 10.1093/rheumatology/26.2.103. [DOI] [PubMed] [Google Scholar]
  14. Kent T. H., Cardelli R. M., Stamler F. W. Small intestinal ulcers and intestinal flora in rats given indomethacin. Am J Pathol. 1969 Feb;54(2):237–249. [PMC free article] [PubMed] [Google Scholar]
  15. Lang J., Price A. B., Levi A. J., Burke M., Gumpel J. M., Bjarnason I. Diaphragm disease: pathology of disease of the small intestine induced by non-steroidal anti-inflammatory drugs. J Clin Pathol. 1988 May;41(5):516–526. doi: 10.1136/jcp.41.5.516. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lanza F. L., Royer G. L., Jr, Nelson R. S., Chen T. T., Seckman C. E., Rack M. F. A comparative endoscopic evaluation of the damaging effects of nonsteroidal anti-inflammatory agents on the gastric and duodenal mucosa. Am J Gastroenterol. 1981 Jan;75(1):17–21. [PubMed] [Google Scholar]
  17. Malech H. L., Gallin J. I. Current concepts: immunology. Neutrophils in human diseases. N Engl J Med. 1987 Sep 10;317(11):687–694. doi: 10.1056/NEJM198709103171107. [DOI] [PubMed] [Google Scholar]
  18. Matthewson K., Pugh S., Northfield T. C. Which peptic ulcer patients bleed? Gut. 1988 Jan;29(1):70–74. doi: 10.1136/gut.29.1.70. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Menzies I. S., Mount J. N., Wheeler M. J. Quantitative estimation of clinically important monosaccharides in plasma by rapid thin layer chromatography. Ann Clin Biochem. 1978 Mar;15(2):65–76. doi: 10.1177/000456327801500116. [DOI] [PubMed] [Google Scholar]
  20. Miller J. J. The imidazoles as immunosuppressive agents. Transplant Proc. 1980 Jun;12(2):300–303. [PubMed] [Google Scholar]
  21. Morris A. J., Madhok R., Sturrock R. D., Capell H. A., MacKenzie J. F. Enteroscopic diagnosis of small bowel ulceration in patients receiving non-steroidal anti-inflammatory drugs. Lancet. 1991 Mar 2;337(8740):520–520. doi: 10.1016/0140-6736(91)91300-j. [DOI] [PubMed] [Google Scholar]
  22. O'Brien J. D., Burnham W. R. Bleeding from peptic ulcers and use of non-steroidal anti-inflammatory drugs in the Romford area. Br Med J (Clin Res Ed) 1985 Dec 7;291(6509):1609–1610. doi: 10.1136/bmj.291.6509.1609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Peoples J. B. Peptic ulcer disease and the nonsteroidal anti-inflammatory drugs. Am Surg. 1985 Jun;51(6):358–362. [PubMed] [Google Scholar]
  24. Price A. B. The Sydney System: histological division. J Gastroenterol Hepatol. 1991 May-Jun;6(3):209–222. doi: 10.1111/j.1440-1746.1991.tb01468.x. [DOI] [PubMed] [Google Scholar]
  25. Satoh H., Guth P. H., Grossman M. I. Role of bacteria in gastric ulceration produced by indomethacin in the rat: cytoprotective action of antibiotics. Gastroenterology. 1983 Mar;84(3):483–489. [PubMed] [Google Scholar]
  26. Sobala G. M., King R. F., Axon A. T., Dixon M. F. Reflux gastritis in the intact stomach. J Clin Pathol. 1990 Apr;43(4):303–306. doi: 10.1136/jcp.43.4.303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Vreugdenhil G., Wognum A. W., van Eijk H. G., Swaak A. J. Anaemia in rheumatoid arthritis: the role of iron, vitamin B12, and folic acid deficiency, and erythropoietin responsiveness. Ann Rheum Dis. 1990 Feb;49(2):93–98. doi: 10.1136/ard.49.2.93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Wallace J. L., Arfors K. E., McKnight G. W. A monoclonal antibody against the CD18 leukocyte adhesion molecule prevents indomethacin-induced gastric damage in the rabbit. Gastroenterology. 1991 Apr;100(4):878–883. doi: 10.1016/0016-5085(91)90259-n. [DOI] [PubMed] [Google Scholar]
  29. Wallace J. L., Keenan C. M., Granger D. N. Gastric ulceration induced by nonsteroidal anti-inflammatory drugs is a neutrophil-dependent process. Am J Physiol. 1990 Sep;259(3 Pt 1):G462–G467. doi: 10.1152/ajpgi.1990.259.3.G462. [DOI] [PubMed] [Google Scholar]
  30. Walt R., Katschinski B., Logan R., Ashley J., Langman M. Rising frequency of ulcer perforation in elderly people in the United Kingdom. Lancet. 1986 Mar 1;1(8479):489–492. doi: 10.1016/s0140-6736(86)92940-5. [DOI] [PubMed] [Google Scholar]
  31. Weiss S. J. Tissue destruction by neutrophils. N Engl J Med. 1989 Feb 9;320(6):365–376. doi: 10.1056/NEJM198902093200606. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES